C12N 2770/32333
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2770/32333 (Use of viral protein as therapeutic agent other than vaccine) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 7
- Inventors
- 11
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Antitumor virus30 Dec 2025US 12,508,291 B2Shanxi Academy of Advanced Research and Innovation
- Genetically engineered coxsackievirus, and pharmaceutical composition16 Jul 2024US 12,037,608 B2N.P.T. S.R.L.
- Combination method for treatment of cancer19 Jul 2022US 11,389,495 B2Merck Sharp & Dohme Corp.
- Methods for treating malignancies using coxsackieviruses13 May 2014US 8,722,036 B2Viralytics Limited
- Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses22 Apr 2008US 7,361,354 B1Viralytics Limited
- Antitumor virus23 Feb 2023US 2023/0057747 A1Shanxi Academy of Advanced Research and Innovation
- Combination method for treatment of cancer24 Sep 2020US 2020/0297788 A1Merck Sharp & Dohme Corp.
- Genetically engineered coxsackievirus, and pharmaceutical composition23 Jul 2020US 2020/0231941 A1Shin Nihon Seiyaku Co., Ltd
- Combination method for treatment of cancer9 May 2019US 2019/0134119 A1Viralytics Limited
- Method of treating a malignancy in a subject and a pharmaceutical composition for use in same7 Dec 2017US 2017/0348366 A1Viralytics Limited
Most cited
By later US patents